Developing a multimodal therapy for glioblastoma using oncolytic virus delivering CD19 and EGFRvIII antigens and bi-specific CARs
- Journal:
- Nature Communications
- Published:
- Affiliations:
- 5
- Authors:
- 11
| Institutions | Authors | Share |
|---|---|---|
| City of Hope, United States of America (USA) | 0.91 | |
| Massachusetts General Hospital (MGH), United States of America (USA) | 0.05 | |
| Harvard Medical School (HMS), United States of America (USA) | 0.05 |